Table I.

Clinical characteristics and characteristics of hypotensive treatment in the study groups (I: group with essential hypertension with left ventricular diastolic dysfunction, II: group with essential hypertension without left ventricular diastolic dysfunction)

Parameter	Group I (n = 57)	Group II (n = 49)	Value of p
Age [years]	46.66 ±12.63	47.78 ±10.75	NS
Height [m]	1.68 ±0.08	1.66 ±0.09	NS
Body mass [kg]	74.28 ±10.50	72.29 ±8.99	NS
BMI [kg/m2]	26.39 ±3.05	25.97 ±2.48	NS
BSA [m2]	1.84 ±0.16	1.81 ±0.15	NS
Gender [%]:
Male	40.35	40.82	NS
Female	59.65	59.18	NS
Duration of essential hypertension [years]	2.21 ±1.49	2.26 ±1.42	NS
Grades of essential hypertension according to ESH/ESC [%]:
Mild	52.63	51.02	NS
Moderate	42.11	46.94	NS
Severe	5.26	2.04	NS
Hypotensive treatment [%]:	100.00	100.00	NS
Monotherapy	45.61	40.82	NS
Combination therapy	54.39	59.18	NS
Hypotensive drugs [%]:	100.00	100.00	NS
ACE inhibitors	57.89	57.14	NS
β-blockers	54.39	55.10	NS
Diuretics	26.32	30.61	NS
Calcium channel blockers	26.32	26.53	NS
Angiotensin receptor blockers	8.77	10.20	NS
Other hypotensive drugs	7.02	8.16	NS
Duration of pharmacological treatment [years]	2.04 ±1.36	2.07 ±1.33	NS

ACE – Angiotensin-converting enzyme inhibitors, BMI – body mass index, BSA – body surface area, ESC – European Society of Cardiology, ESH – European Society of Hypertension.